New cancer therapy appears promising in pre-clinical trails

Oct 06, 2010

A new method for treating breast cancer is showing early promise in pre-clinical trials.

Researchers in the College of Science at Virginia Tech have developed molecular compounds that, when activated by laser light, have the ability to destroy without many of the side effects of most current therapies.

The research team, led by professors Karen Brewer in chemistry and Brenda Winkel in biological sciences, along with Theralase Technologies, a manufacturer of medical laser devices, has developed a way to eradicate tumors without the harmful side effects of , or a surgeon’s scalpel. The group has built what Brewer calls a molecular machine: It seeks out fast-replicating cancer cells and becomes lethal only when exposed to light.

When combined with a deep-penetrating laser from Theralase, the new molecule could help combat fast-growing cancers, such as breast, prostate, and lung, which up until now have not been able to be penetrated by light therapies.

“This research brings the potential for tremendous impact on a devastating disease, and we are excited to be working with world-class researchers at Virginia Tech to further develop this technology,”said Roger Dumoulin-White, CEO of Theralase.

The treatment recently began Phase II trials as part of a seven-year road map for Food and Drug Administration approval.

Meanwhile, Popular Mechanics has named the research and development team a Breakthrough Innovator in its sixth annual awards program. The awards recognize 10 inventors and 10 products poised to change the world in the fields of technology, medicine, aviation, and environmental engineering, among others.

“Our diverse, inspired winners are making the seemingly impossible a reality,” said James B. Meigs, editor-in-chief of the magazine. “The 2010 honorees are the people and products leading the way into the future, and we’re thrilled to recognize their advances. “

The Virginia Tech/Theralase team joins nine others in celebrating the innovator awards. Among the other inventions are soccer balls that generate light and cell phones that diagnose medical conditions.

“This recognition is truly an honor,” Brewer said. “We have been working as a team to develop more effective and less toxic cancer-fighting drugs for the past 18 years. It never ceases to amaze me what this type of team effort can accomplish.”

Brewer said the research has been assisted by students at every level, undergraduates all the way up to postdoctoral Fellows.

“This project is now an exciting example of translational research, collaborating with industry specialists, to take the promise of basic research to clinical trials and beyond.” Winkel said.

Explore further: Prosocial internet support group not beneficial for breast cancer

More information: Popular Mechanics, published monthly by Hearst Magazines, is read by 9 million people and engages readers with the latest innovations in science and technology. The award winners will be highlighted in the November issue, which will be on newsstands Oct. 12.

Provided by Virginia Polytechnic Institute and State University

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

New sensor nanotechnology simplifies disease detection

Oct 04, 2010

Researchers at Stony Brook University have developed a new sensor nanotechnology that could revolutionize personalized medicine by making it possible to instantly detect and monitor disease by simply exhaling ...

Broken bones and medication

Oct 05, 2010

Although one in four women over 50 develops osteoporosis, most are unaware they have the disease — something Professor Suzanne Cadarette would like to change.

New nanoparticles could improve cancer treatment

Oct 05, 2010

In recent years, studies have shown that for many types of cancer, combination drug therapy is more effective than single drugs. However, it is usually difficult to get the right amount of each drug to the ...

Are we getting enough vitamin D?

Oct 04, 2010

Researchers at the Queensland Institute of Medical Research (QIMR) are on a mission to find out if we need to supplement our diet with vitamin D.

Recommended for you

Immune checkpoint inhibitors may work in brain cancers

Nov 21, 2014

New evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases was presented today by Dr Anna Sophie Berghoff at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland.

New model of follow up for breast cancer patients

Nov 21, 2014

Public health researchers from the University of Adelaide have evaluated international breast cancer guidelines, finding that there is potential to improve surveillance of breast cancer survivors from both a patient and health ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

CancerFree
not rated yet Oct 07, 2010
It's Great To Hear Their Using Lasers To Fight Cancer Cells. I Hate Cancer Side Effects! They have come a long way to avoid or reduce the side effects, but you still have to deal with the chemotherapy effects.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.